Ebpay生命医药出版社

  1. Ebpay生命

    102677

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.4 Breast Cancer (Dove Med Press)
    • 3.2 Clin Epidemiol
    • 2.6 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.7 Clin Interv Aging
    • 5.1 Drug Des Dev Ther
    • 3.1 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.6 Int J Women's Health
    • 2.9 Neuropsych Dis Treat
    • 2.8 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.2 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 3.0 Diabet Metab Synd Ob
    • 3.2 Psychol Res Behav Ma
    • 3.4 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.0 Risk Manag Healthc Policy
    • 4.1 J Inflamm Res
    • 2.0 Int J Gen Med
    • 3.4 J Hepatocell Carcinoma
    • 3.0 J Asthma Allergy
    • 2.2 Clin Cosmet Investig Dermatol
    • 2.4 J Multidiscip Healthc



    更多详情 >>





    已发表论文

    瑞马唑仑联合丙泊酚用于镇静胃肠镜检查可减少低氧血症并缩短恢复时间

     

    Authors Zou HD , Luo C, Hu ZL , Zhou P , Luo RY 

    Received 22 January 2025

    Accepted for publication 22 April 2025

    Published 6 May 2025 Volume 2025:19 Pages 3703—3713

    DOI http://doi.org/10.2147/DDDT.S515783

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 2

    Editor who approved publication: Professor Manfred Ogris

    Hai-Ding Zou,1,2 Cong Luo,1,2 Zhao-Lan Hu,1,2 Pei Zhou,1,2 Ru-Yi Luo1,2 

    1Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Anesthesia Medical Research Center, Central South University, Changsha, People’s Republic of China

    Correspondence: Ru-Yi Luo, Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Central Ren-Min Road No. 139, Changsha, Hunan, 410011, People’s Republic of China, Email luoruyi@csu.edu.cn

    Background: Hypoxemia is the most common adverse event during painless gastrointestinal endoscopy (PGIE). This study aimed to evaluate whether the combined use of remimazolam besylate and ciprofol (group RC) reduces the incidence of hypoxemia compared to ciprofol alone (group C) in patients undergoing PGIE under deep sedation.
    Methods: A total of 246 patients scheduled for PGIE were recruited from the Second Xiangya Hospital of Central South University and randomly assigned to group C or RC. The primary outcome measured was the incidence of intraoperative hypoxemia. Secondary outcomes included physiological parameters such as blood pressure, heart rate, and oxygen saturation (SpO2) during the procedure, along with time to loss of consciousness (LoC), time to awakening, and major adverse effects (MAEs). Additionally, correlations between minimum SpO2 and factors like body mass index (BMI), age, and preoperative SpO2 were examined.
    Results: Group C exhibited a significantly higher incidence and frequency of hypoxemia compared to group RC. Correlation analysis revealed that minimum SpO2 was inversely related to age and BMI, while showing a positive correlation with preoperative SpO2. Additionally, the RC group demonstrated significantly decreased induction and shorter times to LoC and awakening than group C.
    Conclusion: The combined administration of ciprofol and remimazolam besylate may enhance the safety profile of deep sedation for PGIE compared to ciprofol alone, offering reduced hypoxemia incidence and improved procedural efficiency.
    Trial Registration: www.chictr.org.cn (Registration number: ChiCTR2400092506, Registration date: November 18, 2024).

    Keywords: hypoxemia, remimazolam besylate, ciprofol, oxygen saturation, sedation

    Download Article[PDF]